Characterization of an ideal amphipathic peptide as a procoagulant agent

Biochemical Journal

Volumn 412, Issue 3, 2008, Pages 545-551

  Ganopolsky, Jorge G ^a   Charbonneau, Sophie ^a   Peng, Henry T ^b   Shek, Pang N ^b   Blostein, Mark D ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Coagulation; Fibrinolysis; Haemostatic peptide; Ideal amphipathic peptide (IAP); Prothrombinase; Tenase

Indexed keywords

BIOCHEMISTRY;

AMPHIPATHIC; AMPHIPATHIC PEPTIDE; FACTOR IXA; FACTOR X; HELICAL PEPTIDES; PROCOAGULANT ACTIVITY;

AMINES;

4 CARBOXYGLUTAMIC ACID; AMINO ACID; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9; IDEAL AMPHIPATHIC PEPTIDE; PEPTIDE; PROCOAGULANT;

AMINO ACID COMPOSITION; ARTICLE; ENZYME ACTIVITY; FIBRINOLYSIS; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; COAGULANTS; FACTOR IXA; FACTOR X; FIBRINOLYSIS; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY;

EID: 45349107140     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071448     Document Type: Article

References (31)

1. Mann, K. G. (2003) Thrombin formation. Chest 124, 4S-10S
2. Mackman, N. (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler. Thromb. Vasc. Biol. 24, 1015-1022
3. Furie, B. and Furie, B. C. (1988) The molecular basis of blood coagulation. Cell 53, 505-518
4. 2+ on the structure of vitamin K-dependent coagulation factors. Haemostasis 26, (Suppl. 1), 45-53
5. Skogen, W. F., Esmon, C. T. and Cox, A. C. (1984) Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase. J. Biol. Chem. 259, 2306-2310
6. Ratcliffe, J. V., Furie, B. and Furie, B. C. (1993) The importance of specific γ-carboxyglutamic acid residues in prothrombin: evaluation by site-specific mutagenesis. J. Biol. Chem. 268, 24339-24345
7. Rawala-Sheikh, R., Ahmad, S. S., Ashby, B. and Walsh, P. N. (1990) Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 29, 2606-2611
8. van Dieijen, G., Tans, G., Rosing, J. and Hemker, H. C. (1981) The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256, 3433-3442
9. Malhotra, O. P., Nesheim, M. E. and Mann, K. G. (1985) The kinetics of activation of normal and γ-carboxyglutamic acid-deficient prothrombins. J. Biol. Chem. 260, 279-287
10. Esmon, C. T., Owen, W. G. and Jackson, C. M. (1974) A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions. J. Biol. Chem. 249, 8045-8047
11. Blostein, M. D., Rigby, A. C., Furie, B. C., Furie, B. and Gilbert, G. E. (2000) Amphipathic helices support function of blood coagulation factor IXa. Biochemistry 39, 12000-12006
12. Cornut, I., Buttner, K., Dasseux, J. L. and Dufourcg, J. (1994) The amphipathic α-helix concept: application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of melittin. FEBS Lett. 349, 29-33
13. Collen, D. (1999) The plasminogen (fibrinolytic) system. Thromb. Haemostasis 82, 259-270
14. Nossel, H. L. and Vogel, H. J. (eds) (1982) Pathobiology of the Endothelial Cell, Academic Press, New York
15. Mannucci, P. M. (1998) Hemostatic drugs. N. Engl. J. Med. 339, 245-253
16. j(i = 2j) peptides to acquire optimal hemolytic activity. Biochim. Biophys. Acta 1416, 161-175
17. Schaefer, A. V., Leslie, B. A., Rischke, J. A., Stafford, A. R., Fredenburgh, J. C. and Weitz, J. I. (2006) Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin. Biochemistry 45, 4257-4265
18. Magnus, W. and Winkler, S. (1966) Hill's Equation, Interscience Publishers, New York
19. Venkatachalapathi, Y. V., Phillips, M. C., Epand, R. M., Epand, R. F., Tytler, E. M., Segrest, J. P. and Anantharamaiah, G. M. (1993) Effect of end group blockage on the properties of a class A amphipathic helical peptide. Proteins 15, 349-359
20. 1H-NMR studies of self-aggregation of melittin in aqueous solution. Biochim. Biophys. Acta 622, 231-244
21. Vogel, C. N., Butkowski, R. J., Mann, K. G. and Lundblad, R. L. (1976) Effect of polylysine on the activation of prothrombin: polylysine substitutes for calcium ions and factor V in the factor Xa catalyzed activation of prothrombin. Biochemistry 15, 3265-3269
22. Lundblad, R. L. and Roberts, H. R. (1982) The acceleration by polylysine of the activation of factor X by factor IXa. Thromb. Res. 25, 319-329
23. Beven, L., Castano, S., Dufourcq, J., Wieslander, A. and Wroblewski, H. (2003) The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. Eur. J. Biochem. 270, 2207-2217
24. Alam, H. B., Chen, Z., Jaskille, A., Querol, R. I., Koustova, E., Inocencio, R., Conran, R., Seufert, A., Ariaban, N., Toruno, K. and Rhee, P. (2004) Application of a zeolite hemostatic agent achieves 100 % survival in a lethal model of complex groin injury in swine. J. Trauma 56, 974-983
25. Papo, N., Shahar, M., Eisenbach, L. and Shai, Y. (2003) A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J. Biol. Chem. 278, 21018-21023
26. Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462, 55-70
27. Biggin, P. C. and Sansom, M. S. (1999) Interactions of α-helices with lipid bilayers: a review of simulation studies. Biophys. Chem. 76, 161-183
28. Dathe, M., Schumann, M., Wieprecht, T., Winkler, A., Beyermann, M., Krause, E., Matsuzaki, K., Murase, O. and Bienert, M. (1996) Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 35, 12612-12622
29. Levi, M., Peters, M. and Buller, H. R. (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit. Care Med. 33, 883-890
30. Boffard, K. D., Riou, B., Warren, B., Choong, P. I., Rizoli, S., Rossaint, R., Axelsen, M. and Kluger, Y. (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J. Trauma 59, 8-15
31. Wedmore, I., McManus, J. G., Pusateri, A. E. and Holcomb, J. B. (2006) A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J. Trauma 60, 655-658